Impacts & Achievements
Of the global production of COVID-19 vaccines are from DCVMN member manufacturers
Vaccine products manufactured by DCVMN member companies, covering the most used and needed vaccines worldwide
8 vaccines technologies
A total of 8 different vaccine technology platforms are being used to develop COVID-19 vaccines between all of our 20 members that are engaging in the COVID-19 vaccine effort
The topics of the publications vary between advancing innovation for vaccine manufacturers from developing countries, DCVMN’s contribution to COVID-19 vaccines capacity, developing-country vaccine manufacturers’ technical capabilities and acceleration of vaccine supply.
Of the vaccines manufactured by member companies have WHO Prequalification
The vaccines manufactured by DCVMN members are supplied to 170 countries, covering many MICs, LMICs and LICs
of Gavi’s vaccines are supplied by DCVMN Member companies. Delivering over 40 products for 19 of Gavi’s 20 target diseases, 12 of these as the sole suppliers ensuring accessibility, availability and affordability
